Literature DB >> 16491843

Homology modeling and molecular docking study of translationally controlled tumor protein and artemisinin.

Jinsun Chae1, Inhee Choi, Choonmi Kim.   

Abstract

Translationally controlled tumor protein (TCTP), also known as histamine releasing factor (HRF), is found abundantly in different eukaryotic cell types. The sequence homology of TCTP between different species is very high, belonging to the MSS4/DSS4 superfamily of proteins. TCTP is involved in both cell growth and human late allergy reaction, as well as having a calcium binding property; however, its primary biological functions remain to be clearly elucidated. In regard to many possible functions, the TCTP of Plasmodium falciparum (Pf) is known to bind with an antimalarial agent, artemisinin, which is activated by heme. It is assumed that the endoperoxide-bridge of artemisinin is opened up by heme to form a free radical, which then eventually alkylates, probably to the Cys14 of PfTCTP. Study of the docking of artemisinin with heme, and subsequently with PfTCTP, was carried out to verify the above hypothesis on the basis of structural interactions. The three dimensional (3D) structure of PfTCTP was built by homology modeling, using the NMR structure of the TCTP of Schizosaccharomyces pombe as a template. The quality of the model was examined based on its secondary structure and biological function, as well as with the use of structure evaluating programs. The interactions between artemisinin, heme and PfTCTP were then studied using the docking program, FlexiDock. The center of the peroxide bond of artemisinin and the Fe of heme were docked within a short distance of 2.6A, implying the strong possibility of an interaction between the two molecules, as proposed. When the activated form of artemisinin was docked on the PfTCTP, the C4-radical of the drug faced towards the sulfur of Cys14 within a distance of 2.48A, again suggesting the possibility of alkylation having occurred. These results confirm the proposed mechanism of the antimalarial effect of artemisinin, which will provide a reliable method for establishing the mechanism of its biological activity using a molecular modeling study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491843     DOI: 10.1007/BF02977468

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  5 in total

1.  Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.

Authors:  Daiki Kobayashi; Mio Hirayama; Yoshihiro Komohara; Souhei Mizuguchi; Masayo Wilson Morifuji; Hironobu Ihn; Motohiro Takeya; Akira Kuramochi; Norie Araki
Journal:  J Biol Chem       Date:  2014-08-04       Impact factor: 5.157

2.  Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.

Authors:  Maria Lucibello; Sara Adanti; Ester Antelmi; Dario Dezi; Stefania Ciafrè; Maria Luisa Carcangiu; Manuela Zonfrillo; Giuseppe Nicotera; Lorenzo Sica; Filippo De Braud; Pasquale Pierimarchi
Journal:  Oncotarget       Date:  2015-03-10

Review 3.  Biological actions of artemisinin: insights from medicinal chemistry studies.

Authors:  Jian Li; Bing Zhou
Journal:  Molecules       Date:  2010-03-08       Impact factor: 4.411

4.  Sequence Analysis and Comparison of TCTP Proteins from Human Protozoan Parasites.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  Acta Parasitol       Date:  2022-02-09       Impact factor: 1.534

5.  An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum.

Authors:  Geoffrey H Siwo; Roger S Smith; Asako Tan; Katrina A Button-Simons; Lisa A Checkley; Michael T Ferdig
Journal:  BMC Genomics       Date:  2015-12-04       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.